Accepted for/Published in: JMIR Cancer
Date Submitted: Feb 16, 2025
Open Peer Review Period: Feb 18, 2025 - Apr 15, 2025
Date Accepted: Apr 21, 2025
(closed for review but you can still tweet)
Evaluating an Artificially Intelligent Chatbot ‘Prostate Cancer Info’ for Providing Quality Prostate Cancer Screening Information: A Cross-Sectional Study
ABSTRACT
Background:
Generative AI Chatbots may be useful tools for supporting shared prostate cancer screening decisions, but the information produced by these tools sometimes lack quality or credibility. ‘Prostate Cancer Info’ is a custom GPT chatbot developed to provide plain-language PrCA information only from websites of key authorities on cancer and peer-reviewed literature.
Objective:
To evaluate the accuracy, completeness, and readability of ‘Prostate Cancer Info’s responses to frequently asked PrCA screening questions.
Methods:
Twenty-three frequently asked PrCA questions were individually input into ‘Prostate Cancer Info.’ Responses were recorded in Microsoft Word and reviewed by two raters for their accuracy and completeness. Readability of content was determined by pasting responses into an online Flesch Kincaid Reading Ease Scores calculator.
Results:
Responses to all questions were accurate and culturally appropriate. Seventeen of twenty-three questions (74%) had complete responses. The average readability of responses was 64.5 (written at an 8th-grade level).
Conclusions:
Generative AI chatbots, such as Prostate Cancer Info, are great starting places for learning about PrCA screening and preparing to engage in shared decision making but should not be used as independent sources of PrCA information because key information may be omitted. Men are encouraged to use these tools to complement information received form a healthcare provider.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.